White matter changes in treatment refractory schizophrenia: Does cognitive control and myelination matter?
- PMID: 29387534
- PMCID: PMC5789151
- DOI: 10.1016/j.nicl.2018.01.010
White matter changes in treatment refractory schizophrenia: Does cognitive control and myelination matter?
Abstract
Widespread white matter abnormalities have been reported in schizophrenia, a disorder frequently characterised as a dysconnection syndrome. White matter connectivity in schizophrenia has been predominantly investigated using diffusion weighted imaging, with reductions in fractional anisotropy throughout the brain often interpreted as an indicator of abnormal myelination. However, diffusion weighted imaging lacks specificity and as such a number of microstructural factors besides myelin may be contributing to these results. We utilised multicomponent driven equilibrium single pulse observation of T1 and T2 (mcDESPOT) in medicated patients with chronic schizophrenia, stratified by treatment response status, and healthy controls, in order to assess myelin water fraction (MWF) in these groups. In addition, we assessed cognitive control using the Stroop task to investigate how response inhibition relates to myelination in patients and controls. Both treatment resistant (n = 22) and treatment responsive (n = 21) patients showed reduced MWF compared to healthy controls (n = 24) in bilateral fronto-occipital fasciculi, particularly evident in the vicinity of the striatum und extending to the cerebellum, with no difference between patient groups. Patients showed greater reaction time interference on the Stroop task compared to healthy controls, with no difference between patient groups. Stroop interference was significantly negatively correlated with MWF in the corpus callosum across groups, and MWF differences in this region mediated the behavioural group effects on the Stroop task. These findings support the suitability of mcDESPOT as a myelin-specific measure of abnormal connectivity in schizophrenia, and suggest that treatment resistant schizophrenia is not characterised by more severe abnormalities in myelination or cognitive control compared to treatment responsive schizophrenia.
Figures




Similar articles
-
Microstructural imaging in temporal lobe epilepsy: Diffusion imaging changes relate to reduced neurite density.Neuroimage Clin. 2020;26:102231. doi: 10.1016/j.nicl.2020.102231. Epub 2020 Feb 28. Neuroimage Clin. 2020. PMID: 32146320 Free PMC article.
-
The Paradoxical Relationship between White Matter, Psychopathology and Cognition in Schizophrenia: A Diffusion Tensor and Proton Spectroscopic Imaging Study.Neuropsychopharmacology. 2015 Aug;40(9):2248-57. doi: 10.1038/npp.2015.72. Epub 2015 Mar 18. Neuropsychopharmacology. 2015. PMID: 25786581 Free PMC article.
-
Myelin Water Fraction Imaging of the Brain in Children with Prenatal Alcohol Exposure.Alcohol Clin Exp Res. 2019 May;43(5):833-841. doi: 10.1111/acer.14024. Epub 2019 Apr 8. Alcohol Clin Exp Res. 2019. PMID: 30889291
-
White matter and cognitive function in schizophrenia.Int J Neuropsychopharmacol. 2007 Aug;10(4):513-36. doi: 10.1017/S1461145707007638. Epub 2007 Feb 21. Int J Neuropsychopharmacol. 2007. PMID: 17313699 Review.
-
White matter in learning, cognition and psychiatric disorders.Trends Neurosci. 2008 Jul;31(7):361-70. doi: 10.1016/j.tins.2008.04.001. Epub 2008 Jun 5. Trends Neurosci. 2008. PMID: 18538868 Free PMC article. Review.
Cited by
-
Shi-Zhen-An-Shen Decoction, a Herbal Medicine That Reverses Cuprizone-Induced Demyelination and Behavioral Deficits in Mice Independent of the Neuregulin-1 Pathway.Neural Plast. 2021 Feb 25;2021:8812362. doi: 10.1155/2021/8812362. eCollection 2021. Neural Plast. 2021. PMID: 33708250 Free PMC article.
-
Cognitive correlates of abnormal myelination in psychosis.Sci Rep. 2019 Mar 26;9(1):5162. doi: 10.1038/s41598-019-41679-z. Sci Rep. 2019. PMID: 30914748 Free PMC article.
-
Harnessing myelin water fraction as an imaging biomarker of human cerebral aging, neurodegenerative diseases, and risk factors influencing myelination: A review.J Neurochem. 2024 Sep;168(9):2243-2263. doi: 10.1111/jnc.16170. Epub 2024 Jul 8. J Neurochem. 2024. PMID: 38973579 Free PMC article. Review.
-
Neural correlates of positive and negative symptoms through the illness course: an fMRI study in early psychosis and chronic schizophrenia.Sci Rep. 2019 Oct 8;9(1):14444. doi: 10.1038/s41598-019-51023-0. Sci Rep. 2019. PMID: 31595009 Free PMC article.
-
Neuropsychological differences between treatment-resistant and treatment-responsive schizophrenia: a meta-analysis.Psychol Med. 2022 Jan;52(1):1-13. doi: 10.1017/S0033291721004128. Epub 2021 Nov 1. Psychol Med. 2022. PMID: 36415088 Free PMC article.
References
-
- Andreasen N.C., Carpenter W.T., Jr., Kane J.M., Lasser R.A., Marder S.R., Weinberger D.R. Remission in schizophrenia: proposed criteria and rationale for consensus. Am. J. Psychiatr. 2005;162(3):441–449. - PubMed
-
- Baron R.M., Kenny D.A. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J. Pers. Soc. Psychol. 1986;51(6):1173. - PubMed
-
- Buckley P.F., Shendarkar N. Treatment-refractory schizophrenia. Curr. Opin. Psychiatry. 2005;18(2):165–173. - PubMed
-
- Canu E., Agosta F., Filippi M. A selective review of structural connectivity abnormalities of schizophrenic patients at different stages of the disease. Schizophr. Res. 2015;161(1):19–28. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical